Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2000, No. 02
(2000; 19 pages)
Table of Contents
View the documentEditorial
View the documentRegulatory matters
View the documentSafety of medicines
View the documentMedical errors
View the documentFeature
View the documentSafety of blood products

WHO Pharmaceuticals Newsletter 2000, No. 02

The aim of this Newsletter is to disseminate information on the safety and efficacy of pharmaceutical products, based on information received from our network of "drug information officers" and other sources such as specialized bulletins and journals, as well as partners in WHO. Information on adverse drug reactions is provided by the WHO Collaborating Centre for International Drug Monitoring. The information is produced in the form of résumés in English full texts of which may be obtained on request from:

Quality Assurance and Safety:
Medicines, EDP-HTP
World Health Organization
1211 Geneva 27, Switzerland
E-mail address: QSM@who.int
Fax: +41 22 791 4730.

Extensive information on medicines may be obtained from our Internet site:

Further information on adverse reactions may be obtained from the WHO Collaborating Centre for International Drug Monitoring,
Stora Torget 3, S-753 20 Uppsala, Sweden
Tel: 46-18-65.60.60; fax: 46-18-65.60.80
E-mail: sten.olsson@who-umc.org
Internet: http://www.who-umc.org


to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017